8S1X image
Entry Detail
PDB ID:
8S1X
Keywords:
Title:
Crystal structure of Actinonin-bound PDF1 and the computationally designed DBAct553_1 protein binder
Biological Source:
PDB Version:
Deposition Date:
2024-02-16
Release Date:
2024-10-30
Method Details:
Experimental Method:
Resolution:
1.88 Å
R-Value Free:
0.20
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Peptide deformylase
Chain IDs:A
Chain Length:168
Number of Molecules:1
Biological Source:Pseudomonas aeruginosa
Polymer Type:polypeptide(L)
Description:DBAct553_1
Chain IDs:B
Chain Length:70
Number of Molecules:1
Biological Source:synthetic construct
Primary Citation
Targeting protein-ligand neosurfaces with a generalizable deep learning tool.
Nature 639 522 531 (2025)
PMID: 39814890 DOI: 10.1038/s41586-024-08435-4

Abstact

Molecular recognition events between proteins drive biological processes in living systems1. However, higher levels of mechanistic regulation have emerged, in which protein-protein interactions are conditioned to small molecules2-5. Despite recent advances, computational tools for the design of new chemically induced protein interactions have remained a challenging task for the field6,7. Here we present a computational strategy for the design of proteins that target neosurfaces, that is, surfaces arising from protein-ligand complexes. To develop this strategy, we leveraged a geometric deep learning approach based on learned molecular surface representations8,9 and experimentally validated binders against three drug-bound protein complexes: Bcl2-venetoclax, DB3-progesterone and PDF1-actinonin. All binders demonstrated high affinities and accurate specificities, as assessed by mutational and structural characterization. Remarkably, surface fingerprints previously trained only on proteins could be applied to neosurfaces induced by interactions with small molecules, providing a powerful demonstration of generalizability that is uncommon in other deep learning approaches. We anticipate that such designed chemically induced protein interactions will have the potential to expand the sensing repertoire and the assembly of new synthetic pathways in engineered cells for innovative drug-controlled cell-based therapies10.

Legend

Protein

Chemical

Disease

Primary Citation of related structures